Edition:
India

Nektar Therapeutics (NKTR.OQ)

NKTR.OQ on NASDAQ Stock Exchange Global Select Market

76.78USD
2:29am IST
Change (% chg)

$5.19 (+7.25%)
Prev Close
$71.59
Open
$72.41
Day's High
$79.69
Day's Low
$72.25
Volume
919,283
Avg. Vol
693,935
52-wk High
$79.69
52-wk Low
$11.42

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.34 December 23 Jan 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 4 4 4 3
(2) OUTPERFORM 4 4 5 5
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.67 1.67 1.70 1.78

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 4 33.43 48.60 24.70 56.81
Quarter Ending Jun-18 4 103.75 246.60 30.50 61.01
Year Ending Dec-18 7 229.88 394.90 126.20 251.27
Earnings (per share)
Quarter Ending Mar-18 5 -0.34 -0.25 -0.40 -0.12
Quarter Ending Jun-18 5 -0.02 0.88 -0.40 -0.13
Year Ending Dec-18 7 -0.90 0.22 -1.58 -0.64

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 117.32 152.93 35.61 30.35
Quarter Ending Jun-17 34.23 34.59 0.36 1.05
Quarter Ending Mar-17 26.80 24.73 2.07 7.73
Quarter Ending Dec-16 40.67 37.45 3.22 7.92
Quarter Ending Sep-16 32.89 36.34 3.44 10.47

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Mar-18 33.43 33.43 38.67 37.06 56.81
Quarter Ending Jun-18 103.75 103.75 92.05 81.71 61.01
Year Ending Dec-18 229.88 233.90 222.30 213.05 251.27

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Mar-18 0 0 0 1
Quarter Ending Jun-18 0 0 0 1
Year Ending Dec-18 0 1 0 1
Earnings